1. Technical Field
This disclosure relates to micro electro mechanical systems (MEMS), including medical devices that encapsulate a fluid or liquid, and related sensor and actuation devices.
2. Description of Related Art
Many microelectromechanical systems (MEMS) based medical devices utilize encapsulated liquids. Some examples include applications for variable-focus liquid lens optics, electrolysis actuators, and electrowetting devices.
For such devices, stiction valves have been used to seal the liquid within the device chamber. Typically, the stiction valves have been placed externally in relation to the liquid chamber and active structures. Such an external valve configuration unnecessarily increases the overall footprint of the device. Attempts at integrating stiction valves within a device active structure have been shown to negatively affect long-term encapsulation due to leakage and poor valve design.
Other medical devices function as neural prostheses, with notable examples being intraocular prostheses and cortical prostheses. At the heart of every neural prosthesis there exists an interface between the tissue and the device structure. Most neural prosthesis function by recording/sensing neural output and/or stimulating tissue via microelectrodes.
Generally, the efficacy of an electronic neural prosthesis, such as an intraocular retinal prosthesis, is highly dependent on the electromechanical coupling or interface between the device and tissue. Factors such as proximity, temperature, pressure, and post-implantation small-scale motion all play an important role to the overall function of a neural prosthesis. Previous techniques have not adequately addressed such factors.
Many contact sensor transduction methods have been explored (piezoresistive, capacitive, conductive polymers, optical, and ultrasound). However, large sensor footprints have precluded their use in device-tissue interfaces.
Aspects of the present disclosure are directed to devices based on microelectromechanical systems (MEMS), including medical devices that utilize flexible housings or chambers to encapsulate liquid and function as sensors and/or actuation devices. Exemplary embodiments of the present disclosure can include a flexible MEMS encapsulated-liquid medical device including a flexible housing having an interior surface defining a chamber and configured to encapsulate a liquid within the chamber; first and second fluidic access ports configured to admit liquid into the chamber; and first and second electrodes, each having a portion exposed to the chamber, in which the first and second electrodes are configured to sense an impedance of a liquid within the chamber.
The device can include a stiction valve configured to seal the chamber.
The housing of the device can include Parylene.
The housing of the device can include Parylene C.
The first and second fluidic access ports can each include an internal and external aperture relative to the housing, in which the internal and external apertures are connected by an access port via.
The device housing can be cylindrical and can have a diameter from about 25 μm to about 1 mm, including any subrange of such.
The device housing can include a substrate and the stiction valve can include a valve plate with a central aperture, in which the central aperture is configured to admit liquid from the first and second fluidic access ports to the chamber when the valve plate is not in contact with the substrate.
Further exemplary embodiments of the present disclosure can include a flexible MEMS encapsulated-liquid medical device including a flexible housing having an interior surface defining a chamber and configured to encapsulate a liquid within the chamber; first and second fluidic access ports configured to admit liquid into the chamber; and first and second electrodes, each having a portion exposed to the chamber, and configured to cause electrolysis of a liquid within the chamber; and at least one electrode disposed on the exterior surface of the housing.
The at least one electrode of the device can be configured as a plurality of electrodes.
The plurality of electrodes can be configured as a microelectrode array (MEA).
The device housing can include Parylene.
The device housing can include Parylene C.
The device can include a stiction valve configured to seal the chamber.
The first and second fluidic access ports can each include an internal and external aperture relative to the housing, in which the internal and external apertures are connected by an access port via.
The device housing can be cylindrical and can have a diameter from about 25 μm to about 1 mm, including any subrange of such.
The device housing can include a substrate and the stiction valve can include a valve plate with a central aperture, in which the central aperture is configured to admit liquid from the first and second fluidic access ports to the chamber when the valve plate is not in contact with the substrate.
Further exemplary embodiments of the present disclosure can provide a method of positioning a surface relative to a medical device, where the medical device includes (i) a flexible housing having a substrate and an interior defining a chamber configured to encapsulate a liquid within the chamber, (ii) first and second electrodes, each having a portion exposed to the chamber, and (iii) and at least one electrode disposed on the exterior surface of the housing. The method can include applying a voltage potential across the first and second electrodes; causing electrolysis of a liquid within the chamber; and moving the exterior surface relative to the substrate.
For the method, the at least one electrode disposed on the exterior surface of the housing can be configured as a microelectrode array (MEA).
For method, the medical device can further include first and second fluidic access ports configured to admit liquid into the chamber.
For the method, the medical device can further include a stiction valve.
For the method, the housing of the medical device can include Parylene.
The method can further include encapsulating liquid within the chamber.
Further exemplary embodiments of the present disclosure can provide a method of sensing force applied to a movable surface of a medical device, where the medical device includes (i) a flexible housing having a substrate, a moveable surface, and an interior defining a chamber configured to encapsulate a liquid within the chamber, and (ii) first and second electrodes, each having a portion exposed to the chamber. The method can include applying a voltage potential across the first and second electrodes; in response to a force applied to the movable surface, sensing an impedance change of a liquid within the chamber; and correlating a sensed impedance change of the liquid to the force applied to the moveable surface.
For method, the medical device can further include first and second fluidic access ports configured to admit liquid into the chamber.
For the method, the medical device can further include a stiction valve.
For the method, the housing of the medical device can include Parylene.
The method can further include encapsulating liquid within the chamber.
These, as well as other components, steps, features, benefits, and advantages, will now become clear from a review of the following detailed description of illustrative embodiments, the accompanying drawings, and the claims.
The drawings disclose illustrative embodiments of the present disclosure. They do not set forth all embodiments. Other embodiments may be used in addition or instead. Details that may be apparent or unnecessary may be omitted to save space or for more effective illustration. Conversely, some embodiments may be practiced without all of the details that are disclosed. When the same numeral appears in different drawings, it refers to the same or like components or steps.
Aspects of the disclosure may be more fully understood from the following description when read together with the accompanying drawings, which are to be regarded as illustrative in nature, and not as limiting. The drawings are not necessarily to scale, emphasis instead being placed on the principles of the disclosure. In the drawings:
While certain embodiments are depicted in the drawings, one skilled in the art will appreciate that the embodiments depicted are illustrative and that variations of those shown, as well as other embodiments described herein, may be envisioned and practiced within the scope of the present disclosure.
Illustrative embodiments are now discussed. Other embodiments may be used in addition or instead. Details that may be apparent or unnecessary may be omitted to save space or for a more effective presentation. Conversely, some embodiments may be practiced without all of the details that are disclosed.
Embodiments of the present disclosure are directed to MEMS-based devices including a flexible housing that forms a chamber for encapsulating a fluid or liquid. The devices also include encapsulated electrodes, portions of which are exposed to the fluid or liquid within the chamber for sensing and/or physical actuation (controlled movement). Embodiments of such devices can function specifically as: contact force sensors; and/or out-of-plane actuators. Device function is enabled by the encapsulation of liquid within the microchamber. Depending on the kind of electrical input applied, the encapsulated electrodes can serve two functions: electrochemical sensing elements; and/or electrolytic electrodes, where portions of the electrodes function as a cathode and an anode for generating gas.
Whether configured as sensors or actuators, devices according to the present disclosure can have a fluidic coupling to the external environment or can be isolated. Fluidic isolation from the surrounding environment can be accomplished by the inclusion of an annular-plate stiction valve within the device. Such valves are activated by stiction and form a complete seal, thereby trapping the desired liquid within the microchamber of the devices.
Exemplary embodiments of such devices/structures can be configured and utilized as medical devices. In addition to medical uses, however, the structures, actuators, and sensors described herein also have many other applications including, but not limited to, the following: the positioning or manipulation of miniature objects (actuator uses), tactile feedback for interrogation of unknown surfaces having fine features (sensor uses), and cushioning of supported objects (structure uses). The individual structures, actuators, or sensors can be arrayed on a supporting substrate (which may be flexible or rigid) to create smart surfaces that allow multiple levels of interaction with the environment, as indicated above. For example, structures in accordance with the present disclosure can be used as sensors for robotic applications for tactile feedback and/or as actuators for fine-scale controlled movement/positioning. Examples of such, can include, but are not limited to use with surgical robots, military robots such as those used for bomb/IED confinement or destruction/mitigation, and robots used for under-water/aquatic applications. Moreover, such structures (sensors and/or actuators) can be used for virtual reality applications. For example, structures (e.g., functioning as sensors) according to the present disclosure can be used as feedback mechanisms for virtual reality programs/environments by translating movement of a user's body (e.g., as detected by use of a glove of other body-covering structure with attached sensors) into signals corresponding to body motion. The virtual reality program/environment can receive the signals and process/accommodate the indicated body motion of the user. Conversely, structures (functioning as actuators) can provide tactile feedback to the user by applying force to the user's skin/body in a controlled manner.
As was noted above, exemplary embodiments of the present disclosure can be utilized for contact force sensor applications. Such contact force sensors can provide a flexible, polymer-based, microscale sensor element capable of operating in wet environments, requiring no hermetic packaging and with the ability to measure microNewton forces. An example of a specific application is the measurement of contact forces between implanted neuroprosthetic devices and the soft tissue with which they are in contact with. Mechanical characterization of contact forces at these locations is difficult, if not impossible, with traditional sensing approaches especially when dealing with polymer-based neural prosthetic devices (such as an epiretinal prosthesis).
In exemplary embodiments, Parylene C can be used as the housing material. Parylene C is a transparent thin-film biocompatible polymer that can be deposited at room temperature through a chemical vapor deposition process. Deposition is generally conformal and pin-hole free and exhibits excellent moisture barrier properties, good mechanical strength, electrical insulating properties, excellent chemical resistance and can be integrated with standard microfabrication techniques. Parylene C has a United States Pharmacopoeia (USP) Class VI biocompatibility standing required for implantable applications. For exemplary embodiments, the diameter of the chamber 102 can be selected as desired over a range of about 25 μm to about 1 mm, including any subrange of such.
With continued reference to
As previously described, the fluid/liquid within a device microchamber can be isolated from fluid exterior to the medical device by integration of valve structure(s) within the device itself.
While the medical devices shown and described for
By application of sufficient voltage and/or current to the electrodes 310, 312, electrolysis of the liquid 304 can be caused to take place within the chamber 302. The integration of a device (such as an electrode or electrode array) on the thin top surface of the chamber/housing 302 can enable the out-of-plane actuation of such of a device. For example,
Particular applications of such actuators (e.g., actuator 300) can be for the micropositioning of recording/stimulation electrodes for use with neural tissue both in-vivo and in-vitro. These actuators can ameliorate problems that have arisen for implanted neuroprosthetic devices that stimulate tissue. For example, there have been cases when the electrodes of such devices have separated from the target tissue. To enable more efficacious and targeted stimulation it is beneficial to reposition these electrodes closer to the tissue. An out-of-plane actuator according to the present disclosure is one way to accomplish this result. The integration of such technology is ideal for polymer-based neurostimulation platforms.
The following description highlight features of exemplary embodiments of the present disclosure.
Sensor 500 consists of a microchamber 502 with a soft contact surface (Parylene C) and a pair of microelectrodes 506, 508 exposed to the contents (e.g., liquid 504) of the microchamber 502. Etched access ports (not shown) on the perimeter of the chamber 502 connect to an internal stiction valve (not shown) trapping fluid 504 within the cavity 502. The top portion of
The lower portion of
To expand of features described above, actuation functionality can be accomplished in the same structure used for a sensor by simply applying a DC (or possibly AC) current or voltage potential across the encapsulated electrodes to generate hydrogen and oxygen gases. The resulting build-up of internal pressure within the chamber can cause the top membrane of the chamber to deform upwards. Such motion can be used advantageously as actuation for controlled positioning.
In this configuration the encapsulated electrodes 606, 608 can be utilized to generate electrolytic gas 616, which increases the pressure within the microchamber 602. The top membrane of the chamber 602 is accordingly moved or actuated upwards, which in turn actuates any attached device or structure 630, e.g., an electrode of microelectrode array (MEA).
As was stated previously, embodiments of flexible MEMS medical devices according to the present disclosure can include stiction valves to isolate the internal chamber fluid from the external fluidic environment.
In the bottom view of
Because force sensing is accomplished electrochemically, the nature of fluid within the chamber is important to sensor calibration. Therefore, if a known fluid is to be used, a stiction valve can be integrated which traps this liquid while the sensor is operated in an environment composed of a separate and distinct liquids (if desired). Force sensing range may be slightly limited in such a configuration because liquid is trapped and is approximately incompressible. The exclusion of a stiction valve enables fluid to flow in and out of the chamber freely. Thus, it is desirable, but not essential, that the environmental fluid be known or characterized in order to calibrate sensor operation in this fluid.
Because actuation is accomplished using electrolytically generated gas, it is possible that some of this gas may escape through the fluidic access ports if enough gas is generated. This can impose a limitation to the amount of pressure which can build in the chamber thereby limiting actuation.
The inclusion of a stiction valve for exemplary embodiments of the present disclosure can solve this problem. Because a stiction valve seals downward towards the substrate, the generation of any pressure in the chamber will serve only to push the valve downward thereby sealing it even more forcefully. This can allow for the generation of high pressures, maximizing actuation.
Table 1—Parameters selected for device fabrication. These parameters were used for tested devices; other devices can be fabricated with variations in these dimensions.
For exemplary embodiments, device fabrication can begin with lithographically defined electrodes (e.g., platinum) patterned on a Parylene substrate. An insulation layer of Parylene can then deposited and patterned in an oxygen plasma thereby removing the insulation over the electrodes. A layer of sacrificial material (photoresist) can then be patterned to form the fluidic access ports and optional stiction valve structures. An additional layer of Parylene can then be deposited and patterned to open the access port vias (and stiction valve central pore). Another layer of sacrificial material can then be deposited and patterned (photoresist) to form the chamber structures. This can be followed by a final deposition of Parylene, forming the final chamber structure. A final Parylene etching step can then reopen vias to the fluidic access ports. The sacrificial material can then be dissolved away by a suitable process, e.g., soaking in acetone and IPA followed by DI water. The chamber finally can then be filled with the desired fluid by immersion in a bath of such a fluid.
For actuation purposes, additional steps may be necessary to integrate a device or structure, such as an additional surface electrode. Stiction valve activation can occur by simply exposing the device to ambient conditions. Evaporation through the access ports can cause the valve to seal due to stiction.
Accordingly, aspects and embodiments of the present disclosure can provide benefits and advantages over previous techniques.
The components, steps, features, benefits and advantages that have been discussed are merely illustrative. None of them, nor the discussions relating to them, are intended to limit the scope of protection in any way. Numerous other embodiments are also contemplated. These include embodiments that have fewer, additional, and/or different components, steps, features, objects, benefits and advantages. These also include embodiments in which the components and/or steps are arranged and/or ordered differently.
For example, while Parylene C has been described as a material for medical devices described herein, other types of parylene and other polymers may be used within the scope of the present disclosure. For example, there are a number of derivatives and isomers of parylene including: Parylene N (hydrocarbon), Parylene C (one chlorine group per repeat unit), Parylene D (two chlorine groups per repeat unit), Parylene AF-4 (generic name, aliphatic flourination 4 atoms), Parylene SF (AF-4, Kisco product), Parylene HT (AF-4, SCS product), Parylene A (one amine per repeat unit, Kisco product), Parylene AM (one methylene amine group per repeat unit, Kisco product), Parylene VT-4 (generic name, fluorine atoms on the aromatic ring), Parylene CF (VT-4, Kisco product), and Parylene X (a cross-linkable version).
Moreover, while embodiments of medical device actuators are described herein as including a device, e.g., electrode, on a movable actuation surface of the device, such devices are optional. Controlled movement or actuation of a surface of a sensor can occur within the scope of the present disclosure.
In addition, while the foregoing description has been given in the context of using two fluidic access ports for chambers/microchambers of medical devices, the use of one or more than two fluidic access ports in included in the scope of the present disclosure.
Unless otherwise stated, all measurements, values, ratings, positions, magnitudes, sizes, and other specifications that are set forth in this specification, including in the claims that follow, are approximate, not exact. They are intended to have a reasonable range that is consistent with the functions to which they relate and with what is customary in the art to which they pertain.
All articles, patents, patent applications, and other publications which have been cited in this disclosure are hereby incorporated herein by reference.
The phrase “means for” when used in a claim is intended to and should be interpreted to embrace the corresponding structures and materials that have been described and their equivalents. Similarly, the phrase “step for” when used in a claim is intended to and should be interpreted to embrace the corresponding acts that have been described and their equivalents. The absence of these phrases in a claim mean that the claim is not intended to and should not be interpreted to be limited to any of the corresponding structures, materials, or acts or to their equivalents.
Nothing that has been stated or illustrated is intended or should be interpreted to cause a dedication of any component, step, feature, object, benefit, advantage, or equivalent to the public, regardless of whether it is recited in the claims.
The scope of protection is limited solely by the claims that now follow. That scope is intended and should be interpreted to be as broad as is consistent with the ordinary meaning of the language that is used in the claims when interpreted in light of this specification and the prosecution history that follows and to encompass all structural and functional equivalents.
This application is based upon and claims priority to the following: U.S. Provisional Patent Application No. 61/154,959, entitled “FLEXIBLE PARYLENE-BASED ELECTRO-MECHANICAL INTERFACE TECHNOLOGY FOR NEURAL PROSTHESES,” filed Feb. 24, 2009, attorney docket USCST-004N; U.S. Provisional Patent Application No. 61/246,891, entitled “AUTOMATIC LIQUID ENCAPSULATION IN PARYLENE MICROCHAMBERS BY INTEGRATED STICTION VALVES,” filed Sep. 9, 2009, attorney docket USCST-007N; and U.S. Provisional Patent Application No. 61/246,892, entitled “MEMS FORCE/TACTILE SENSORS BASED ON TRANSDUCTION OF ENCAPSULATED LIQUID WITHIN PARYLENE MICROSTRUCTURES,” filed Sep. 9, 2009, attorney docket USCST-008N. The entire content of all of these applications is incorporated herein by reference.
This invention was made with Government support under Contract No. EEC-0310723 awarded by the National Science Foundation (NSF), and Contract No. ECS-0547544 awarded by the National Science Foundation (NSF). The Government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2010/025248 | 2/24/2010 | WO | 00 | 8/23/2011 |
Number | Date | Country | |
---|---|---|---|
61154959 | Feb 2009 | US | |
61246892 | Sep 2009 | US | |
61246891 | Sep 2009 | US |